8-KEarnings & ResultsOther EventsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jan 30, 2025)

Filed January 30, 2025For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on January 30, 2025, to report its financial and operational updates. The filing primarily references a press release containing the company's results for the fourth quarter and full year ended December 31, 2024. While specific financial figures from the press release are not detailed within the 8-K itself, this release is a key source of information for investors assessing the company's recent performance. The 8-K also highlights a significant capital return initiative, signaling confidence in the company's financial health and commitment to shareholder value.

Key Highlights

  • 1Quest Diagnostics announced its financial results for the quarter and full year ended December 31, 2024, via a press release filed with the SEC.
  • 2The company's Board of Directors authorized a 6.7% increase in its quarterly dividend.
  • 3The quarterly dividend will increase from $0.75 to $0.80 per share.
  • 4This dividend increase translates to an annualized dividend of $3.20 per share.
  • 5The increased dividend is effective for the payment on April 21, 2025.
  • 6Quest Diagnostics has a history of increasing its dividend annually since 2011.
  • 7The press release containing the financial results and dividend announcement is attached as Exhibit 99.1.

Frequently Asked Questions

The 8-K filing on January 30, 2025, references a press release that announces Quest Diagnostics' results for the quarter and full year ended December 31, 2024. The specific financial metrics (revenue, earnings, etc.) are detailed within the referenced press release (Exhibit 99.1), which is incorporated by reference.

Quest Diagnostics' Board of Directors authorized a 6.7% increase in its quarterly dividend, raising it from $0.75 to $0.80 per share. This new dividend rate will be effective with the payment on April 21, 2025.

The fact that Quest Diagnostics has raised its dividend annually since 2011 demonstrates a consistent commitment to returning capital to shareholders and suggests management's confidence in the company's ongoing financial stability and ability to generate consistent profits.

The detailed financial results for the quarter and full year ended December 31, 2024, along with the announcement of the dividend increase, are provided in the press release attached as Exhibit 99.1 to this 8-K filing.